Tribal individuals presented with fever and uni-or bi-lateral parotitis in Galonda and Silli villages (Dadra and Nagar Haveli, India) between 2 October 2016 and 19 March 2017. Consequently, the magnitude and epidemiological characteristics of the outbreak were investigated. Overall, 139 cases of suspected mumps were identified in both the above villages. Most of the suspected cases were 5-15 years old, the exceptions being three adults who had no noticeable complications. Specimens were collected from 42 of the suspected cases and their close contacts (n ¼ 39) for laboratory investigation. Mumps infection was laboratory-confirmed in 73.8% and 20.5% of the suspected cases and contacts, respectively. Mumps was confirmed in seven adults aged 17-42 years, including three suspected cases and four contacts. To the best of our knowledge, this is the first report of a complete virus genome circulating among tribal individuals. Sequencing and phylogenetic studies revealed circulation of mumps virus genotype G in these tribal villages with 99% identity to a mumps virus detected in the UK (1996) and Canada (2009). Comparison with Indian mumps viruses revealed 99% and 98% identity to previously reported isolates from Pune during 2012 and 1986, respectively. Although the outbreak was large, no major complications were reported in the tribal villages. Detection of asymptomatic mumps in numerous close contacts indicates the importance of laboratory investigations in an outbreak setting.
INTRODUCTION
Mumps, an important public health problem worldwide, can be prevented by administration of live attenuated vaccines (1) . Mumps is a neglected disease in many developing countries; receiving more attention in the USA, Canada, UK, and other European countries. The disease is characterized by fever with swelling of parotid and other salivary glands; possible complications include deafness, orchitis, oophoritis, pancreatitis, meningitis and encephalitis (2) (3) (4) . Mumps is caused by a highly infectious RNA virus (15, 384 nucleotides) that belongs to the Paramyxoviridae family and Rubulavirus genus.
Mumps virus is serologically a monotypic virus; hence, available vaccines provide protection against the circulating MuV genotypes. To date, circulation of 12 genotypes of MuV has been reported from different countries (5) . Interestingly, mumps outbreaks attributable to mumps genotype G strains have been reported from countries in which measles, mumps and rubella (MMR) vaccine is routinely administered (6) (7) (8) . There are very few countries in which mumps-containing vaccines are not a component of the routine immunization schedule; these include India. Circulation of MuV genotype G has previously been reported from two Indian states (9) (10) (11) .
Limited data are available on the epidemiology of mumps in India (12) . MuV-containing vaccines are not a component of India's UIP; however, they are available as an optional vaccine. The Indian Academy of Pediatrics recommends two doses of mumps vaccine in the UIP, at the ages of 9 months and 16-24 months (13) . Mumps is not a notifiable disease in India and there is currently no mumps surveillance system. Thus, the molecular epidemiology of mumps virus in India has not been properly studied.
From 2-9 October 2016 and 13-19 March 2017, tribal residents of Galonda and Silli villages (DNH, India) presented with fever and evidence of parotitis. An epidemiological investigation was performed to assess the characteristics and determinants of this disease in tribal individuals. Furthermore, laboratory investigations, including serological and molecular testing, virus isolation and full genome sequencing of the circulating virus were undertaken. Full MuV genomes were studied to identify mutations in structural and nonstructural genes.
MATERIALS AND METHODS

Outbreak setting
The tribal zone of Silli and Galonda villages is situated near (less than 2 km) the border of Gujarat State, India. The local Integrated Disease Surveillance Program team reported that some tribal residents of Silli and Galonda village were experiencing 2-3 days fever with evidence of parotitis. The populations of Galonda and Silli villages are 6900 and 8285, respectively, and none of either village's residents was immunized against mumps.
Cases, contact definition and field investigations
Previous definitions of cases and contact were used in this study (9, 14) . Clinically suspected cases of mumps in Silli and Galonda villages were reported between 2 October 2016 and 19 March 2017. Initially, an investigation team comprising a medical officer and healthcare staff was formed. An epidemiological investigation was carried out using spot maps of the affected areas. Subsequently, clinical specimens (81 serum samples, two throat swabs and two urine specimens) were collected for laboratory diagnosis.
Twenty-six serum samples from suspected cases and 24 from neighbors or family contacts from Galonda village were collected between 13 December 2016 and 25 January 2017 (48th week of 2016 and third week of 2017). Similarly, 16 serum samples from suspected cases and 15 from neighbors or family contacts from Silli village were collected between 2 October 2016 and 4 December 2016 (40th-48th week). In total, 81 serum samples, two throat swabs and two urine specimens) were collected from 42-suspected cases and 39 contacts and transported within 12 hr on icepacks to the main laboratory.
Mumps specific IgM and IgG antibody detection
Serum samples from 40 suspected cases (serum samples were not available from two cases) and 39 contacts were assessed for presence of mumps specific IgM and IgG antibodies using commercial enzyme immuno assay kits (Siemens Healthcare Diagnostics Products GmbH, Erlangen, Germany). According to the kits' criteria, the qualitative results were noted as negative, positive or equivocal. Other assay validation criteria provided in the kits' inserts were strictly observed.
Mumps virus RT-PCR, virus isolation and genome sequencing
Initially, mumps SH gene RT-PCR was performed on nine clinical specimens (throat swab and urine specimens) collected from patients with suspected mumps, as described previously (11) . Mumps RT-PCR positive specimens, that is, throat swabs and urine specimens obtained from two confirmed cases were subjected to virus isolation using 24-hr-old Vero cells. Altogether, three blind passages were performed to confirm MuV isolation. Distinct cytopathic effects in tissue culture flasks were confirmed by MuV (SH gene) RT-PCR, followed by full genome sequencing. In addition, acute serum samples that were found to be negative or equivocal by mumps-specific IgM enzyme immuno assay were subjected to mumps RT-PCR.
In brief, viral RNA was extracted from 0.5 mL of tissue culture fluid (of each MuV isolate) using a commercial kit (Qiagen, Hilden, Germany). RNA was reconstituted in nuclease free water and stored at À80°C. The MuV genome was subsequently amplified using a set of primers (11) . A set of overlapping fragments was amplified in each RT-PCR reaction using a One-step RT-PCR kit (Invitrogen, Carlsbad, CA, USA) in a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, CA, USA), as described previously (11) . The PCR products were purified using a QIAamp DNA Minikit (Qiagen) and both DNA strands sequenced using the same set of primers. Sequencing reactions was performed using a DyeDeoxy terminator sequencing kit (Applied Biosystems). Furthermore, sequencing reactions were purified using a Dye Ex 2.0 Spin Kit (Qiagen) and sequences obtained using an automated sequencer (ABI/Hitachi 3730XL, DNA Analyzer (96); Tokyo, Japan). Consensus sequences were deduced from the forward and reverse sequence reads. Full genomes were compared with mumps reference and vaccine sequences, as described previously (11) .
RESULTS
Epidemiological description
Between 2 October 2016 and 19 March 2017, 22 and 117 mumps cases were reported from Silli and Galonda villages, respectively. The week-wise distribution of mumps cases in the two villages is presented in Figure 1 . A combined epicurve showed two peaks in mumps cases in the 40th-42nd weeks of 2016 and 52nd week to 2016 to 5th week of 2017. It is interesting to note that this outbreak continued intermittently for 5-6 months without any major clinical complications in suspected or confirmed cases. Most of the individuals with suspected mumps were 0 to 15 years old (n ¼ 128, 92%), only 7.9% of cases being adults (Table 1 ). More precisely, the majority of individuals with mumps were aged 5-9 yrs (n ¼ 65) or 10-15 yrs (n ¼ 55) in both villages (Table S1 ). Women and girls (57.3%) comprised a greater percentage of cases than men and boys (42.7%) in Galonda village, whereas in Silli village there was a greater proportion of men and boys (59.1%) than women and girls (40.9%); however, there were fewer cases in the latter village. Overall, 20.5% contacts were found to have asymptomatic mumps infection.
Laboratory investigations
Specimens from 42 of the 139 suspected cases were available for laboratory testing. Mumps was 
Mumps virus full genome
The full genomes of the mumps genotype G viruses detected in this outbreak (KY604739 and MG460606) showed 99% identity with full genomes from the UK (AF280799), Canada (KY680537) and Pune-2012 (KF738114) strains, and 98% identity with the Pune-1986 (KF738113) strain (Fig. 4) . Comparisons with mumps Jeryl Lynn vaccine and reference genotype G strain (AF280799) revealed 42 and 31 aa substitutions, respectively, across the genome. The percent aa identity was 96.49% in the SH region and 98.51%-99.66% in other regions. Comparison with reference sequence (MuVi/Gloucester.GBR/32.96) revealed the most numerous aa changes in the large gene (n ¼ 10), followed by eight aa changes in the F gene, five in the phosphoprotein (V/P) gene, and two in each of the nucleoprotein, matrix, SH, and HN genes (Table S3) . Interestingly, aa changes were not found in the important sites present in the HN and F regions. Table S3 .
DISCUSSION
Few reports of mumps outbreaks in tribal groups in India are available. Similarly, very scanty information is available on the epidemiology of mumps, its incidence and antibody prevalence in India (12) . A cluster of mumps cases in tribal individuals from DNH was recently investigated (14) . However, the circulating mumps virus genotype was not determined because of lack of appropriate throat swabs or urine specimens, whereas in the present study two mumps viruses were isolated and a full genome sequence of circulating mumps virus (genotype G) determined. Because mumps virus was only isolated from Silli village and not from Galonda village, a full genome sequence is available only for Silli village. However, this mumps outbreak was epidemiologically linked to both villages. Comparison of the full genome sequence with those of two previously sequenced mumps genotype G strains from Maharashtra state (11) revealed 98-99% identity. However, the origin of the MuV isolates could not be tracked because of a lack of information on any travel by local residents or outsiders. Given that phylogenetic analysis of the full genome revealed clustering of the DNH isolate with previously detected Indian viruses, it is likely that the virus originated from indigenous residents of India. It is important to note that mutations were not reported in the important sites/ epitopes present in HN and F genes.
We here report on a large outbreak of mumps in tribal residents of Dadra and Nagar Haveli that lasted for 5-6 months. Crowding and intensity of exposure are important risk factors for mumps transmission (4) . The salient feature of this outbreak was the large number of cases (n ¼ 139) from two neighboring villages that are less than 2 km apart. The suspected cases reported typical symptoms of mumps (namely fever and uni-or bi-lateral parotitis) along with other symptoms such as headache, body pain, weakness, loss of appetite, nausea, swelling or pain in lymph glands, shoulder stiffness, difficulty in deglutition, cough, earache and pain in the throat. The primary treatment was provided by a Primary Health Centre. A few individuals refused treatment because of their tribal customs and beliefs. Lack of health awareness and poor sanitation likely contributed to the clustering of mumps cases in these two villages. However, isolation of individuals with mumps cases was essential to minimize further spread of infection. Additionally, 11 adults from the two villages had symptoms of mumps; three of these were laboratory-confirmed. It is possible that other organisms were responsible for some of the suspected cases. Timing of collection of specimens is a crucial factor. Interestingly, none of the affected tribal individuals reported complications or required hospitalization for mumps. In a previous a massive outbreak of mumps in Osmanabad district (Maharashtra state, India) two patients had complications, namely meningo-encephalitis and encephalitis, and one died (9) . Thus, administration of mumps-containing vaccines through UIP would have the advantage of reducing mumps-associated morbidity in tribal settings.
About 1/3rd of mumps infections are reportedly asymptomatic in unimmunized populations (5) , whereas the rate of asymptomatic infections is slightly higher in immunized populations (15) (16) (17) . In the present study, 20.5% of close contacts aged between 8 and 42 years had asymptomatic mumps infection. Of the 39 contacts assessed, asymptomatic infection was diagnosed in four contacts from each of Galonda and Silli villages, all affected contacts being family members, neighbors or schoolmates. Interestingly, because isolation of cases is difficult in tribal settings because of their social and cultural traditions, the risk of transmission of infection to the close or neighborhood contacts is likely higher than in other settings.
In conclusion, whole genome sequencing and phylogenetic studies revealed circulation of mumps genotype G strain in tribal villages of DNH with 99% identity to the mumps strains reported from the UK (1996) and Canada (2009). Comparison with Indian isolates revealed 99% identity to Pune-2012 and 98% identity to Pune-1986 mumps strains. Although this was a large outbreak, no major complications were identified in these tribal villages. Most of the affected individuals were children. Asymptomatic mumps in numerous close contacts indicates the importance of laboratory investigations in an outbreak setting.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version of this article at the publisher's web-site. Table S1 . Age groups and cases reported from the two investigated tribal villages. Table S2 . Laboratory results on specimens from cases and contacts from the two investigated villages. Table S3 . Genetic variability of MuV isolate with reference to strains detected from the UK, Canada, USA, Japan and Croatia.
